Slot, Stefanie <br/><br/>
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  10 2019 
 - 624-634 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2019.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Janus Kinase 2--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Nitriles<br/>Platelet Count<br/>Primary Myelofibrosis--blood<br/>Pyrazoles--adverse effects<br/>Pyrimidines<br/>Retrospective Studies<br/>Thrombocytopenia--blood